Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bio-Gate AGSTU:BIG 30 OCF Margin % is -9.91% as of Dec. 2025. GuruFocus rates STU:BIG with a GF Score™ of 30/100. The stock has 7 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Bio-Gate AG ranks worse than 72.27% on this metric.
The historical rank and industry rank for Bio-Gate AG's OCF Margin % or its related term are showing as below:
STU:BIG'
s OCF Margin % Range Over the Past 10 Years
Min: -35.98 Med: -13.55 Max: 7.74
Current: -13.61
During the past 13 years, the highest OCF Margin % of Bio-Gate AG was 7.74%. The lowest was -35.98%. And the median was -13.55%.
STU:BIG's OCF Margin % is ranked worse than 72.27% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.75
vs STU:BIG: -13.61
The historical data trend for Bio-Gate AG's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:BIG vs ISRG, BDX, MDLN: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Bio-Gate AG's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Gate AG OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bio-Gate AG's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Bio-Gate AG's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Gate AG (STU:BIG) has a OCF Margin % of -9.91% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bio-Gate AG and its competitors. According to the industry distribution chart, Bio-Gate AG ranks #589 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 72.3%.
Is Bio-Gate AG's OCF Margin % too high?
Bio-Gate AG's current OCF Margin % is -9.91%. Based on the distribution chart, Bio-Gate AG ranks #589 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Bio-Gate AG has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Gate AG's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bio-Gate AG ranks #589 out of 815 companies for OCF Margin %. This places Bio-Gate AG in the lower half of its industry. The industry median OCF Margin % is 5.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.75, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bio-Gate AG and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bio-Gate AG's current OCF Margin % is -9.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Gate AG stock overvalued right now?
Bio-Gate AG (STU:BIG) has a current OCF Margin % of -9.91%. The current OCF Margin % is -9.91%. Bio-Gate AG's overall GF Score™ is 30/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Bio-Gate AG (STU:BIG), the current OCF Margin % is -9.91% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Bio-Gate AG is a Germany based medical technology company. The company employs silver technology to endow materials and products with antimicrobial properties. It is focused on the medical technology products portfolio. In addition, its technologies are also used to refine cosmetics, consumer goods, and industrial products. The products of the company are plasma-coating, additives, textile solutions, spray, masterbatches, and others. The organization uses two different technologies; first, silver particles are incorporated into cosmetics, paints, veneers or plastics, and second involve coating final products like implants or wound dressings with a silver-containing functional layer.
30GF Score
Get the complete analysis for STU:BIG
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:BIG has been successfully added to your 
